FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024956212> ?p ?o ?g. }

• W2024956212 endingPage "e0122073" @default.
• W2024956212 startingPage "e0122073" @default.
• W2024956212 abstract "Background Soluble tumor necrosis factor receptors 1 (sTNFR1) and 2 (sTNFR2) have been associated to progression of renal failure, end stage renal disease and mortality in early stages of chronic kidney disease (CKD), mostly in the context of diabetic nephropathy. The predictive value of these markers in advanced stages of CKD irrespective of the specific causes of kidney disease has not yet been defined. In this study, the relationship between sTNFR1 and sTNFR2 and the risk for adverse cardiovascular events (CVE) and all-cause mortality was investigated in a population with CKD stage 4-5, not yet on dialysis, to minimize the confounding by renal function. Patients and methods In 131 patients, CKD stage 4-5, sTNFR1, sTNFR2 were analysed for their association to a composite endpoint of all-cause mortality or first non-fatal CVE by univariate and multivariate Cox proportional hazards models. In the multivariate models, age, gender, CRP, eGFR and significant comorbidities were included as covariates. Results During a median follow-up of 33 months, 40 events (30.5%) occurred of which 29 deaths (22.1%) and 11 (8.4%) first non-fatal CVE. In univariate analysis, the hazard ratios (HR) of sTNFR1 and sTNFR2 for negative outcome were 1.49 (95% confidence interval (CI): 1.28-1.75) and 1.13 (95% CI: 1.06-1.20) respectively. After adjustment for clinical covariables (age, CRP, diabetes and a history of cardiovascular disease) both sTNFRs remained independently associated to outcomes (HR: sTNFR1: 1.51, 95% CI: 1.30-1.77; sTNFR2: 1.13, 95% CI: 1.06-1.20). A subanalysis of the non-diabetic patients in the study population confirmed these findings, especially for sTNFR1. Conclusion sTNFR1 and sTNFR2 are independently associated to all-cause mortality or an increased risk for cardiovascular events in advanced CKD irrespective of the cause of kidney disease." @default.
• W2024956212 created "2016-06-24" @default.
• W2024956212 creator A5014740176 @default.
• W2024956212 creator A5048572756 @default.
• W2024956212 creator A5072366606 @default.
• W2024956212 creator A5083345780 @default.
• W2024956212 creator A5085120063 @default.
• W2024956212 date "2015-03-30" @default.
• W2024956212 modified "2023-10-12" @default.
• W2024956212 title "Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study" @default.
• W2024956212 cites W1540192329 @default.
• W2024956212 cites W1817120227 @default.
• W2024956212 cites W1987383000 @default.
• W2024956212 cites W2006538317 @default.
• W2024956212 cites W2019434041 @default.
• W2024956212 cites W2026679068 @default.
• W2024956212 cites W2029774820 @default.
• W2024956212 cites W2051969301 @default.
• W2024956212 cites W2056707218 @default.
• W2024956212 cites W2064448614 @default.
• W2024956212 cites W2066523471 @default.
• W2024956212 cites W2068103783 @default.
• W2024956212 cites W2076982231 @default.
• W2024956212 cites W2087714796 @default.
• W2024956212 cites W2088657493 @default.
• W2024956212 cites W2091200828 @default.
• W2024956212 cites W2096305848 @default.
• W2024956212 cites W2101841456 @default.
• W2024956212 cites W2111329158 @default.
• W2024956212 cites W2113454700 @default.
• W2024956212 cites W2115034481 @default.
• W2024956212 cites W2115931410 @default.
• W2024956212 cites W2116732368 @default.
• W2024956212 cites W2117637609 @default.
• W2024956212 cites W2134163777 @default.
• W2024956212 cites W2140697776 @default.
• W2024956212 cites W2143782633 @default.
• W2024956212 cites W2151053450 @default.
• W2024956212 cites W2155965977 @default.
• W2024956212 cites W2162778769 @default.
• W2024956212 cites W2169918634 @default.
• W2024956212 cites W2321491775 @default.
• W2024956212 cites W2475261460 @default.
• W2024956212 cites W2607031541 @default.
• W2024956212 doi "https://doi.org/10.1371/journal.pone.0122073" @default.
• W2024956212 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4379033" @default.
• W2024956212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25823004" @default.
• W2024956212 hasPublicationYear "2015" @default.
• W2024956212 type Work @default.
• W2024956212 sameAs 2024956212 @default.
• W2024956212 citedByCount "49" @default.
• W2024956212 countsByYear W20249562122015 @default.
• W2024956212 countsByYear W20249562122016 @default.
• W2024956212 countsByYear W20249562122017 @default.
• W2024956212 countsByYear W20249562122018 @default.
• W2024956212 countsByYear W20249562122019 @default.
• W2024956212 countsByYear W20249562122020 @default.
• W2024956212 countsByYear W20249562122021 @default.
• W2024956212 countsByYear W20249562122022 @default.
• W2024956212 countsByYear W20249562122023 @default.
• W2024956212 crossrefType "journal-article" @default.
• W2024956212 hasAuthorship W2024956212A5014740176 @default.
• W2024956212 hasAuthorship W2024956212A5048572756 @default.
• W2024956212 hasAuthorship W2024956212A5072366606 @default.
• W2024956212 hasAuthorship W2024956212A5083345780 @default.
• W2024956212 hasAuthorship W2024956212A5085120063 @default.
• W2024956212 hasBestOaLocation W20249562121 @default.
• W2024956212 hasConcept C126322002 @default.
• W2024956212 hasConcept C134018914 @default.
• W2024956212 hasConcept C144301174 @default.
• W2024956212 hasConcept C151730666 @default.
• W2024956212 hasConcept C159641895 @default.
• W2024956212 hasConcept C188816634 @default.
• W2024956212 hasConcept C207103383 @default.
• W2024956212 hasConcept C2778653478 @default.
• W2024956212 hasConcept C2779343474 @default.
• W2024956212 hasConcept C2779978075 @default.
• W2024956212 hasConcept C2908647359 @default.
• W2024956212 hasConcept C38180746 @default.
• W2024956212 hasConcept C44249647 @default.
• W2024956212 hasConcept C50382708 @default.
• W2024956212 hasConcept C50440223 @default.
• W2024956212 hasConcept C555293320 @default.
• W2024956212 hasConcept C71924100 @default.
• W2024956212 hasConcept C86803240 @default.
• W2024956212 hasConcept C99454951 @default.
• W2024956212 hasConceptScore W2024956212C126322002 @default.
• W2024956212 hasConceptScore W2024956212C134018914 @default.
• W2024956212 hasConceptScore W2024956212C144301174 @default.
• W2024956212 hasConceptScore W2024956212C151730666 @default.
• W2024956212 hasConceptScore W2024956212C159641895 @default.
• W2024956212 hasConceptScore W2024956212C188816634 @default.
• W2024956212 hasConceptScore W2024956212C207103383 @default.
• W2024956212 hasConceptScore W2024956212C2778653478 @default.
• W2024956212 hasConceptScore W2024956212C2779343474 @default.
• W2024956212 hasConceptScore W2024956212C2779978075 @default.
• W2024956212 hasConceptScore W2024956212C2908647359 @default.
• W2024956212 hasConceptScore W2024956212C38180746 @default.

• next